Study of oxidative stress in patients of psoriasis

Manpreet Kaur, Saurabh Sharma, Sahiba Kukreja, Jasleen Kaur, Roopam Bassi


Background: Psoriasis is a well-recognized chronic inflammatory papulosquamous disorder characterized by the formation of salmon colored papules and plaques with silvery white scales. The aim of this study was to do a comparative evaluation of the parameters of oxidative stress, namely glutathione peroxidase, malondialdehyde and superoxide dismutase in patients of psoriasis with normal healthy subjects

Methods: 60 subjects in the age group of 30-70 years were included in the study; Group A consisted of 30 newly diagnosed psoriasis patients presenting to the Dermatology OPD and Group B consisted of 30 normal healthy individuals. Thorough history taking and clinical examination were done. The punch biopsy was performed for histopathological examination and markers of oxidative stress were measured in each case and these values were then compared to healthy controls and statistical analysis was performed.

Results: On comparison of the two groups, the levels of anti-oxidants superoxide dismutase and glutathione peroxidase were found to be decreased in psoriasis patients (168.46±51.89 U/ml and 4121.63±1812.53 U/ml respectively) as compared to controls (237±39.30 U/ml and 8435±1397.54 U/ml respectively) which was statistically highly significant (p <0.001) and the level of pro-oxidant malondialdehyde was found to be increased in patients of psoriasis (0.42±0.13 nmol/ml) in contrast to controls (0.08±0.06 nmol/ml)which was also statistically highly significant (p <0.001).

Conclusions: Keeping in consideration the increased oxidative stress in the patients of psoriasis, the anti-oxidant drugs can form an important part of the therapeutic ladder of psoriasis. 


Psoriasis, Oxidative stress, Malondialdehyde, Superoxide dismutase, Glutathione peroxidase

Full Text:



Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. The Lancet. 2007;370(9583):263–71.

MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgrad Med J. 2007;83(985):690-7.

Azfar SR, Joel MG. Psoriasis and Metabolic Disease: Epidemiology and Pathophysiology. Curr Opin Rheumatol. 2008;20(4):416-22.

Langley RGB, Kruger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(2):18–23.

Mahajan R, Handa S. Pathophysiology of psoriasis. Indian J Dermatol Venereol Leprol. 2013;79(1):1-9.

Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What’s new. J Eur Acad Dermatol Venereol. 2003;17(6):663–9.

Corrocher R, Ferrari S, Gironcoli M, Bassi A, Olivieri O, Guarini P. Effect of fish oil supplementation on erythrocyte lipid pattern, malondialdehyde production and glutathione-peroxidase activity in psoriasis. Clin Chim Acta. 1989;179(2):121–31.

Florence TM. The role of free radicals in disease. Aust N Z J Ophthalmol.1995;23(1):3-7.

Haan JBD, Cristiano F, Lannello RC, Kola I. Cu/Zn-superoxide dismutase and glutathione peroxidise during ageing. Biochem Mol Biol Int. 1995;35(6):1281-97.

Marklund S, Marklund G. Involvement of superoxide anion radical in autooxidation of pyrogallol and a convenient assay of superoxide dismutases. Eur J Biochem. 1974;47(3):469-74.

Nandi A, Chatterjee IB. Assay of superoxide dismutase activity in animal tissue. J Biosci. 1988;13(3):305-15.

Wendel A. Enzymatic Basis of Detoxication. NY: Academic Press; 1980: 333

Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chem Acta. 1978;90(1):37-43.

Relhan V, Gupta SK, Dayal S, Pandey R, Lal H. Blood thiols and malondialdehyde levels in psoriasis. J Dermatol. 2002;29:399–403.

Orient A, Donko A, Szabo A, Leto TL, Geiszt M. Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant.2007;2:1281-8.

Wozniak A, Drewa G, Krzyzynka-Malinowska E, Czajkowski R, Protas-Drozd F, Mila-Kierzenkowska C, et al. Oxidant antioxidant balance in patients with psoriasis. Med Sci Monit. 2007;13(1):30–3.

Drewa G, Krzyzyńska ME, Woźniak A, Protas DF, Mila KC, Rozwodowska M, et al. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Med Sci Monit. 2002;8(8):338-43.

Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of Oxidative Stress in Various Stages of Psoriasis. Ind J Clin Biochem. 2010;25(4):388–92.

Bacchetti T, Campanati A, Ferretti G, Simonetti O, Liberati G, Offidani AM. Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment. Br J Dermatol. 2013;168(5):984-9.